2591O Efficacy of cabozantinib and nivolumab in cluster 1/2 metastatic clear cell renal cell carcinoma: Results from OPTIC RCC, a phase II trial of a novel RNAseq-based biomarker
S.M. Haake, Kathryn E. Beckermann, Pedro C. Barata, Moshe Chaim Ornstein, Nataliya Mar, YW Chen, L L Walls, Jason R. Brown, Clint Gray, Christopher Eing Wee, Alex Nesta, Eric S. Davis, Ellen Heimann-Nichols, Tian Zhang, Anupama Reddy, Brian I. Rini
Topics & Concepts
MedicineCabozantinibNivolumabClear cell renal cell carcinomaBiomarkerCancer researchClear cellPhases of clinical researchOncologyKidney cancerCluster (spacecraft)CellRenal cell carcinomaKidneyPhase (matter)Internal medicineClinical trialPathologyTyrosine-kinase inhibitorRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersRenal and related cancers